Valuation: Beijing Tiantan Biological Products Co., Ltd.

Capitalization 38.88B 5.42B 4.64B 4.32B 4.02B 7.42B 465B 8.25B 51.76B 19.79B 218B 20.34B 19.92B 799B P/E ratio 2025 *
22.9x
P/E ratio 2026 * 20.1x
Enterprise value 34.66B 4.84B 4.13B 3.85B 3.58B 6.62B 415B 7.36B 46.15B 17.64B 194B 18.13B 17.76B 713B EV / Sales 2025 *
5.11x
EV / Sales 2026 * 4.37x
Free-Float
46.44%
Yield 2025 *
0.44%
Yield 2026 * 0.59%
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.20%
1 week+1.34%
Current month+2.45%
1 month-0.76%
3 months-12.51%
6 months+3.04%
Current year-4.10%
More quotes
1 week 19.51
Extreme 19.51
20.21
1 month 18.88
Extreme 18.88
20.21
Current year 18.88
Extreme 18.88
23.61
1 year 18.88
Extreme 18.88
27.6
3 years 16.11
Extreme 16.1083
27.6
5 years 12.44
Extreme 12.4444
37.15
10 years 6.53
Extreme 6.5347
37.15
More quotes
Manager TitleAgeSince
Investor Relations Contact - 28/02/2006
Corporate Secretary 46 31/12/2002
Director of Finance/CFO 55 25/04/2017
Director TitleAgeSince
Chairman 58 04/12/2022
Director/Board Member 51 24/05/2017
Chairman 63 31/10/2016
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-0.20%+1.34%-17.29%+9.99% 5.42B
-0.61%-0.76%-20.24%-16.34% 76.69B
+1.43%+3.72%-47.44%-7.60% 59.99B
-2.13%+5.70%+29.69%+27.50% 54.72B
-0.96%+1.21%+18.22%+97.45% 37.99B
-0.83%+1.01%-43.32%-37.65% 19.67B
+0.37%-6.55%+110.04%+120.99% 17.54B
-2.23%+16.91%+62.89%+752.43% 17.06B
-0.04%-.--%+68.37%+138.03% 14.02B
-2.49%+0.20%+10.11%-15.28% 13.28B
Average -1.07%+0.82%+17.10%+106.95% 31.64B
Weighted average by Cap. -1.19%+1.12%+3.38%+61.65%
See all sector performances

Financials

2025 *2026 *
Net sales 6.78B 946M 809M 753M 701M 1.29B 81.17B 1.44B 9.03B 3.45B 38B 3.55B 3.47B 139B 7.65B 1.07B 912M 850M 790M 1.46B 91.55B 1.62B 10.18B 3.89B 42.87B 4B 3.92B 157B
Net income 1.72B 240M 205M 191M 178M 329M 20.61B 365M 2.29B 877M 9.65B 901M 882M 35.4B 1.96B 273M 234M 218M 202M 374M 23.43B 415M 2.61B 997M 10.97B 1.02B 1B 40.25B
Net Debt -4.21B -588M -503M -468M -435M -804M -50.42B -894M -5.61B -2.14B -23.61B -2.2B -2.16B -86.6B -5.47B -764M -653M -608M -566M -1.05B -65.51B -1.16B -7.29B -2.79B -30.67B -2.86B -2.8B -113B
More financial data * Estimated data
Logo Beijing Tiantan Biological Products Co., Ltd.
BEIJING TIANTAN BIOLOGICAL PRODUCTS CORPORATION LIMITED is a China-based company principally engaged in the biopharmaceutical businesses. The Company’s primary products include preventive products, blood products and other biological products, such as the influenza A (H1N1) vaccines (split, inactivated),hepatitis B vaccines, poliomyelitis vaccines, measles-mump-rubella (MMR) vaccines, encephalitis B vaccines, influenza vaccinations, bacterial vaccines, human serum albumin (HSA) and intravenous immunoglobulin (IVIG), among others. The Company mainly distributes its products within domestic markets and to Hong Kong markets.
Employees
5,298
More about the company
Date Price Change Volume
11/07/25 19.66 ¥ -0.20% 12,941,180
10/07/25 19.70 ¥ +0.05% 10,340,320
09/07/25 19.69 ¥ +0.10% 15,854,650
08/07/25 19.67 ¥ -0.61% 17,942,040
07/07/25 19.79 ¥ +2.01% 30,613,790

End-of-day quote Shanghai S.E., July 10, 2025

More quotes
Trading Rating
Investor Rating
ESG MSCI
CCC
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
19.66CNY
Average target price
28.00CNY
Spread / Average Target
+42.42%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. 600161 Stock